世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

血液RNAチューブの世界市場成長 2023-2029


Global Blood RNA Tube Market Growth 2023-2029

LPI（LPインフォメーション）の最新調査によると、世界の血液RNAチューブ市場規模は2022年に1億8100万米ドルとなった。下流市場での需要の増加に伴い、血液RNAチューブは2029年までに2億4,060万米ドルの再調整規... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション 		2023年10月30日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		94 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

LPI（LPインフォメーション）の最新調査によると、世界の血液RNAチューブ市場規模は2022年に1億8100万米ドルとなった。下流市場での需要の増加に伴い、血液RNAチューブは2029年までに2億4,060万米ドルの再調整規模になると予測され、レビュー期間中のCAGRは4.1%である。
この調査レポートは、世界の血液RNAチューブ市場の成長可能性を明らかにしています。血液RNAチューブは今後の市場で安定した成長を示すと予想される。しかし、血液RNAチューブの普及には、製品の差別化、コスト削減、サプライチェーンの最適化が依然として重要である。市場関係者は、研究開発への投資、戦略的パートナーシップの構築、進化する消費者の嗜好に合わせた製品提供など、Blood RNA Tube市場が提供する莫大な機会を活用する必要がある。
分子診断検査用の全血サンプル採取用
当社の調査によると、医療機器の世界市場は2023年に6,030億米ドルと推定され、今後6年間は年平均成長率5％で成長する。世界の医療支出は世界のGDPの10％を占め、高齢化による健康ニーズの増加、慢性疾患や感染症の流行、新興市場の拡大により、近年増加の一途をたどっている。医療機器市場は、ヘルスケア産業において重要な役割を果たしている。同市場は、世界的な高度医療サービスに対する需要の増加、医療技術の進歩、高齢者人口の増加、医療費の増加、病気の早期診断と治療に対する意識の高まりなど、いくつかの要因によって牽引されている。
主な特徴
この調査レポートは、血液RNAチューブ市場の様々な側面を反映し、業界に関する貴重な洞察を提供しています。
市場規模と成長：この調査レポートは、血液RNAチューブ市場の現在の規模と成長の概要を提供しています。過去データ、タイプ別市場区分（例：2.5ml、6mL）、地域別内訳などが含まれます。
市場の促進要因と課題：政府規制、環境問題、技術の進歩、消費者の嗜好の変化など、血液RNAチューブ市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができます。
競合情勢：この調査レポートは、血液RNAチューブ市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれています。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。
技術開発：調査レポートは、血液RNAチューブ産業における最新の技術開発を掘り下げることができます。これには、血液RNAチューブ技術の進歩、血液RNAチューブの新規参入、血液RNAチューブの新規投資、血液RNAチューブの将来を形作るその他の技術革新が含まれます。
川下の事業者の好み：この調査レポートは、Blood RNA Tube市場における顧客の購買行動と採用動向を明らかにします。顧客の購買決定や血液RNAチューブ製品の嗜好に影響を与える要因も含まれています。
政府の政策とインセンティブ：調査レポートは、政府の政策とインセンティブが血液RNAチューブ市場に与える影響を分析します。これには、規制枠組み、補助金、税制優遇措置、血液RNAチューブ市場の促進を目的としたその他の措置の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性調査レポートは、血液RNAチューブ市場の環境への影響と持続可能性の側面を評価します。
市場予測と将来展望：調査レポートは、実施した分析に基づいて、血液RNAチューブ産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、血液RNAチューブ市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
血液RNAチューブ市場はタイプ別と用途別に分類される。2018年から2029年までの期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。
タイプ別セグメント
2.5 mL
6 mL
その他
用途別セグメント
病院
クリニック
その他
本レポートでは、市場を地域別にも分割しています：
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
BDバイオサイエンス
サーモフィッシャーサイエンティフィック
Zhixuanバイオテクノロジー
南京兎歯生物学
マグバイオ・ゲノミクス
テンポス
バイオテック
ザイモ・リサーチ
Hbxinle
本レポートで扱う主な質問
世界の血液RNAチューブ市場の10年展望は？
世界および地域別に、血液RNAチューブ市場の成長を促進する要因は何か？
市場別、地域別で最も急成長する技術は何か？
血液RNAチューブの市場機会は最終市場規模によってどのように異なるのか？
血液RNAチューブのタイプ別、用途別内訳は？


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Blood RNA Tube Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Blood RNA Tube by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Blood RNA Tube by Country/Region, 2018, 2022 & 2029
2.2 Blood RNA Tube Segment by Type
2.2.1 2.5 ml
2.2.2 6 mL
2.2.3 Other
2.3 Blood RNA Tube Sales by Type
2.3.1 Global Blood RNA Tube Sales Market Share by Type (2018-2023)
2.3.2 Global Blood RNA Tube Revenue and Market Share by Type (2018-2023)
2.3.3 Global Blood RNA Tube Sale Price by Type (2018-2023)
2.4 Blood RNA Tube Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Blood RNA Tube Sales by Application
2.5.1 Global Blood RNA Tube Sale Market Share by Application (2018-2023)
2.5.2 Global Blood RNA Tube Revenue and Market Share by Application (2018-2023)
2.5.3 Global Blood RNA Tube Sale Price by Application (2018-2023)
3 Global Blood RNA Tube by Company
3.1 Global Blood RNA Tube Breakdown Data by Company
3.1.1 Global Blood RNA Tube Annual Sales by Company (2018-2023)
3.1.2 Global Blood RNA Tube Sales Market Share by Company (2018-2023)
3.2 Global Blood RNA Tube Annual Revenue by Company (2018-2023)
3.2.1 Global Blood RNA Tube Revenue by Company (2018-2023)
3.2.2 Global Blood RNA Tube Revenue Market Share by Company (2018-2023)
3.3 Global Blood RNA Tube Sale Price by Company
3.4 Key Manufacturers Blood RNA Tube Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood RNA Tube Product Location Distribution
3.4.2 Players Blood RNA Tube Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Blood RNA Tube by Geographic Region
4.1 World Historic Blood RNA Tube Market Size by Geographic Region (2018-2023)
4.1.1 Global Blood RNA Tube Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Blood RNA Tube Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Blood RNA Tube Market Size by Country/Region (2018-2023)
4.2.1 Global Blood RNA Tube Annual Sales by Country/Region (2018-2023)
4.2.2 Global Blood RNA Tube Annual Revenue by Country/Region (2018-2023)
4.3 Americas Blood RNA Tube Sales Growth
4.4 APAC Blood RNA Tube Sales Growth
4.5 Europe Blood RNA Tube Sales Growth
4.6 Middle East & Africa Blood RNA Tube Sales Growth
5 Americas
5.1 Americas Blood RNA Tube Sales by Country
5.1.1 Americas Blood RNA Tube Sales by Country (2018-2023)
5.1.2 Americas Blood RNA Tube Revenue by Country (2018-2023)
5.2 Americas Blood RNA Tube Sales by Type
5.3 Americas Blood RNA Tube Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood RNA Tube Sales by Region
6.1.1 APAC Blood RNA Tube Sales by Region (2018-2023)
6.1.2 APAC Blood RNA Tube Revenue by Region (2018-2023)
6.2 APAC Blood RNA Tube Sales by Type
6.3 APAC Blood RNA Tube Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Blood RNA Tube by Country
7.1.1 Europe Blood RNA Tube Sales by Country (2018-2023)
7.1.2 Europe Blood RNA Tube Revenue by Country (2018-2023)
7.2 Europe Blood RNA Tube Sales by Type
7.3 Europe Blood RNA Tube Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Blood RNA Tube by Country
8.1.1 Middle East & Africa Blood RNA Tube Sales by Country (2018-2023)
8.1.2 Middle East & Africa Blood RNA Tube Revenue by Country (2018-2023)
8.2 Middle East & Africa Blood RNA Tube Sales by Type
8.3 Middle East & Africa Blood RNA Tube Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood RNA Tube
10.3 Manufacturing Process Analysis of Blood RNA Tube
10.4 Industry Chain Structure of Blood RNA Tube
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood RNA Tube Distributors
11.3 Blood RNA Tube Customer
12 World Forecast Review for Blood RNA Tube by Geographic Region
12.1 Global Blood RNA Tube Market Size Forecast by Region
12.1.1 Global Blood RNA Tube Forecast by Region (2024-2029)
12.1.2 Global Blood RNA Tube Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Blood RNA Tube Forecast by Type
12.7 Global Blood RNA Tube Forecast by Application
13 Key Players Analysis
13.1 BD Biosciences
13.1.1 BD Biosciences Company Information
13.1.2 BD Biosciences Blood RNA Tube Product Portfolios and Specifications
13.1.3 BD Biosciences Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BD Biosciences Main Business Overview
13.1.5 BD Biosciences Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Blood RNA Tube Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Zhixuan Biotechnology
13.3.1 Zhixuan Biotechnology Company Information
13.3.2 Zhixuan Biotechnology Blood RNA Tube Product Portfolios and Specifications
13.3.3 Zhixuan Biotechnology Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zhixuan Biotechnology Main Business Overview
13.3.5 Zhixuan Biotechnology Latest Developments
13.4 Nanjing Rabbit Tooth Biology
13.4.1 Nanjing Rabbit Tooth Biology Company Information
13.4.2 Nanjing Rabbit Tooth Biology Blood RNA Tube Product Portfolios and Specifications
13.4.3 Nanjing Rabbit Tooth Biology Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Nanjing Rabbit Tooth Biology Main Business Overview
13.4.5 Nanjing Rabbit Tooth Biology Latest Developments
13.5 MagBio Genomics
13.5.1 MagBio Genomics Company Information
13.5.2 MagBio Genomics Blood RNA Tube Product Portfolios and Specifications
13.5.3 MagBio Genomics Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 MagBio Genomics Main Business Overview
13.5.5 MagBio Genomics Latest Developments
13.6 Tempus
13.6.1 Tempus Company Information
13.6.2 Tempus Blood RNA Tube Product Portfolios and Specifications
13.6.3 Tempus Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Tempus Main Business Overview
13.6.5 Tempus Latest Developments
13.7 Bioteke
13.7.1 Bioteke Company Information
13.7.2 Bioteke Blood RNA Tube Product Portfolios and Specifications
13.7.3 Bioteke Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bioteke Main Business Overview
13.7.5 Bioteke Latest Developments
13.8 Zymo Research
13.8.1 Zymo Research Company Information
13.8.2 Zymo Research Blood RNA Tube Product Portfolios and Specifications
13.8.3 Zymo Research Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Zymo Research Main Business Overview
13.8.5 Zymo Research Latest Developments
13.9 Hbxinle
13.9.1 Hbxinle Company Information
13.9.2 Hbxinle Blood RNA Tube Product Portfolios and Specifications
13.9.3 Hbxinle Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hbxinle Main Business Overview
13.9.5 Hbxinle Latest Developments
14 Research Findings and Conclusion

　

ページTOPに戻る


　

Summary

According to our LPI (LP Information) latest study, the global Blood RNA Tube market size was valued at US$ 181 million in 2022. With growing demand in downstream market, the Blood RNA Tube is forecast to a readjusted size of US$ 240.6 million by 2029 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Blood RNA Tube market. Blood RNA Tube are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Blood RNA Tube. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Blood RNA Tube market.
For collection of whole blood samples for molecular diagnostic testing
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Blood RNA Tube market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Blood RNA Tube market. It may include historical data, market segmentation by Type (e.g., 2.5 ml, 6 mL), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Blood RNA Tube market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Blood RNA Tube market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Blood RNA Tube industry. This include advancements in Blood RNA Tube technology, Blood RNA Tube new entrants, Blood RNA Tube new investment, and other innovations that are shaping the future of Blood RNA Tube.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Blood RNA Tube market. It includes factors influencing customer ' purchasing decisions, preferences for Blood RNA Tube product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Blood RNA Tube market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Blood RNA Tube market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Blood RNA Tube market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Blood RNA Tube industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Blood RNA Tube market.
Market Segmentation:
Blood RNA Tube market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
2.5 ml
6 mL
Other
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD Biosciences
Thermo Fisher Scientific
Zhixuan Biotechnology
Nanjing Rabbit Tooth Biology
MagBio Genomics
Tempus
Bioteke
Zymo Research
Hbxinle
Key Questions Addressed in this Report
What is the 10-year outlook for the global Blood RNA Tube market?
What factors are driving Blood RNA Tube market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood RNA Tube market opportunities vary by end market size?
How does Blood RNA Tube break out type, application?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Blood RNA Tube Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Blood RNA Tube by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Blood RNA Tube by Country/Region, 2018, 2022 & 2029
2.2 Blood RNA Tube Segment by Type
2.2.1 2.5 ml
2.2.2 6 mL
2.2.3 Other
2.3 Blood RNA Tube Sales by Type
2.3.1 Global Blood RNA Tube Sales Market Share by Type (2018-2023)
2.3.2 Global Blood RNA Tube Revenue and Market Share by Type (2018-2023)
2.3.3 Global Blood RNA Tube Sale Price by Type (2018-2023)
2.4 Blood RNA Tube Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Blood RNA Tube Sales by Application
2.5.1 Global Blood RNA Tube Sale Market Share by Application (2018-2023)
2.5.2 Global Blood RNA Tube Revenue and Market Share by Application (2018-2023)
2.5.3 Global Blood RNA Tube Sale Price by Application (2018-2023)
3 Global Blood RNA Tube by Company
3.1 Global Blood RNA Tube Breakdown Data by Company
3.1.1 Global Blood RNA Tube Annual Sales by Company (2018-2023)
3.1.2 Global Blood RNA Tube Sales Market Share by Company (2018-2023)
3.2 Global Blood RNA Tube Annual Revenue by Company (2018-2023)
3.2.1 Global Blood RNA Tube Revenue by Company (2018-2023)
3.2.2 Global Blood RNA Tube Revenue Market Share by Company (2018-2023)
3.3 Global Blood RNA Tube Sale Price by Company
3.4 Key Manufacturers Blood RNA Tube Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood RNA Tube Product Location Distribution
3.4.2 Players Blood RNA Tube Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Blood RNA Tube by Geographic Region
4.1 World Historic Blood RNA Tube Market Size by Geographic Region (2018-2023)
4.1.1 Global Blood RNA Tube Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Blood RNA Tube Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Blood RNA Tube Market Size by Country/Region (2018-2023)
4.2.1 Global Blood RNA Tube Annual Sales by Country/Region (2018-2023)
4.2.2 Global Blood RNA Tube Annual Revenue by Country/Region (2018-2023)
4.3 Americas Blood RNA Tube Sales Growth
4.4 APAC Blood RNA Tube Sales Growth
4.5 Europe Blood RNA Tube Sales Growth
4.6 Middle East & Africa Blood RNA Tube Sales Growth
5 Americas
5.1 Americas Blood RNA Tube Sales by Country
5.1.1 Americas Blood RNA Tube Sales by Country (2018-2023)
5.1.2 Americas Blood RNA Tube Revenue by Country (2018-2023)
5.2 Americas Blood RNA Tube Sales by Type
5.3 Americas Blood RNA Tube Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood RNA Tube Sales by Region
6.1.1 APAC Blood RNA Tube Sales by Region (2018-2023)
6.1.2 APAC Blood RNA Tube Revenue by Region (2018-2023)
6.2 APAC Blood RNA Tube Sales by Type
6.3 APAC Blood RNA Tube Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Blood RNA Tube by Country
7.1.1 Europe Blood RNA Tube Sales by Country (2018-2023)
7.1.2 Europe Blood RNA Tube Revenue by Country (2018-2023)
7.2 Europe Blood RNA Tube Sales by Type
7.3 Europe Blood RNA Tube Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Blood RNA Tube by Country
8.1.1 Middle East & Africa Blood RNA Tube Sales by Country (2018-2023)
8.1.2 Middle East & Africa Blood RNA Tube Revenue by Country (2018-2023)
8.2 Middle East & Africa Blood RNA Tube Sales by Type
8.3 Middle East & Africa Blood RNA Tube Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood RNA Tube
10.3 Manufacturing Process Analysis of Blood RNA Tube
10.4 Industry Chain Structure of Blood RNA Tube
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood RNA Tube Distributors
11.3 Blood RNA Tube Customer
12 World Forecast Review for Blood RNA Tube by Geographic Region
12.1 Global Blood RNA Tube Market Size Forecast by Region
12.1.1 Global Blood RNA Tube Forecast by Region (2024-2029)
12.1.2 Global Blood RNA Tube Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Blood RNA Tube Forecast by Type
12.7 Global Blood RNA Tube Forecast by Application
13 Key Players Analysis
13.1 BD Biosciences
13.1.1 BD Biosciences Company Information
13.1.2 BD Biosciences Blood RNA Tube Product Portfolios and Specifications
13.1.3 BD Biosciences Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BD Biosciences Main Business Overview
13.1.5 BD Biosciences Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Blood RNA Tube Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Zhixuan Biotechnology
13.3.1 Zhixuan Biotechnology Company Information
13.3.2 Zhixuan Biotechnology Blood RNA Tube Product Portfolios and Specifications
13.3.3 Zhixuan Biotechnology Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zhixuan Biotechnology Main Business Overview
13.3.5 Zhixuan Biotechnology Latest Developments
13.4 Nanjing Rabbit Tooth Biology
13.4.1 Nanjing Rabbit Tooth Biology Company Information
13.4.2 Nanjing Rabbit Tooth Biology Blood RNA Tube Product Portfolios and Specifications
13.4.3 Nanjing Rabbit Tooth Biology Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Nanjing Rabbit Tooth Biology Main Business Overview
13.4.5 Nanjing Rabbit Tooth Biology Latest Developments
13.5 MagBio Genomics
13.5.1 MagBio Genomics Company Information
13.5.2 MagBio Genomics Blood RNA Tube Product Portfolios and Specifications
13.5.3 MagBio Genomics Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 MagBio Genomics Main Business Overview
13.5.5 MagBio Genomics Latest Developments
13.6 Tempus
13.6.1 Tempus Company Information
13.6.2 Tempus Blood RNA Tube Product Portfolios and Specifications
13.6.3 Tempus Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Tempus Main Business Overview
13.6.5 Tempus Latest Developments
13.7 Bioteke
13.7.1 Bioteke Company Information
13.7.2 Bioteke Blood RNA Tube Product Portfolios and Specifications
13.7.3 Bioteke Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bioteke Main Business Overview
13.7.5 Bioteke Latest Developments
13.8 Zymo Research
13.8.1 Zymo Research Company Information
13.8.2 Zymo Research Blood RNA Tube Product Portfolios and Specifications
13.8.3 Zymo Research Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Zymo Research Main Business Overview
13.8.5 Zymo Research Latest Developments
13.9 Hbxinle
13.9.1 Hbxinle Company Information
13.9.2 Hbxinle Blood RNA Tube Product Portfolios and Specifications
13.9.3 Hbxinle Blood RNA Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hbxinle Main Business Overview
13.9.5 Hbxinle Latest Developments
14 Research Findings and Conclusion

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

LP Information社の医療分野での最新刊レポート

本レポートと同じKEY WORD（blood）の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/19　10:26

155.94 円

162.31 円

199.02 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.